IL143905A0 - Novel streptococcus antigens - Google Patents

Novel streptococcus antigens

Info

Publication number
IL143905A0
IL143905A0 IL14390599A IL14390599A IL143905A0 IL 143905 A0 IL143905 A0 IL 143905A0 IL 14390599 A IL14390599 A IL 14390599A IL 14390599 A IL14390599 A IL 14390599A IL 143905 A0 IL143905 A0 IL 143905A0
Authority
IL
Israel
Prior art keywords
streptococcus antigens
novel streptococcus
novel
antigens
streptococcus
Prior art date
Application number
IL14390599A
Other languages
English (en)
Original Assignee
Shire Biochem Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22351610&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL143905(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Shire Biochem Inc filed Critical Shire Biochem Inc
Publication of IL143905A0 publication Critical patent/IL143905A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Neurosurgery (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL14390599A 1998-12-23 1999-12-20 Novel streptococcus antigens IL143905A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11380098P 1998-12-23 1998-12-23
PCT/CA1999/001218 WO2000039299A2 (fr) 1998-12-23 1999-12-20 Antigenes de streptococcus

Publications (1)

Publication Number Publication Date
IL143905A0 true IL143905A0 (en) 2002-04-21

Family

ID=22351610

Family Applications (3)

Application Number Title Priority Date Filing Date
IL14390599A IL143905A0 (en) 1998-12-23 1999-12-20 Novel streptococcus antigens
IL143905A IL143905A (en) 1998-12-23 2001-06-21 Streptococcus antigens
IL194230A IL194230A (en) 1998-12-23 2008-09-21 Streptococcus antigens and processes for their production

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL143905A IL143905A (en) 1998-12-23 2001-06-21 Streptococcus antigens
IL194230A IL194230A (en) 1998-12-23 2008-09-21 Streptococcus antigens and processes for their production

Country Status (30)

Country Link
EP (2) EP2261358B1 (fr)
JP (2) JP4761623B2 (fr)
KR (4) KR100802198B1 (fr)
CN (3) CN101134775A (fr)
AP (1) AP2001002199A0 (fr)
AR (1) AR029322A1 (fr)
AT (1) ATE394489T1 (fr)
AU (1) AU1764900A (fr)
BR (1) BR9916477A (fr)
CA (1) CA2356836C (fr)
CL (1) CL2009002037A1 (fr)
CY (3) CY1108223T1 (fr)
CZ (2) CZ303675B6 (fr)
DE (1) DE69938670D1 (fr)
DK (3) DK1950302T3 (fr)
EA (1) EA007409B1 (fr)
ES (3) ES2400280T3 (fr)
HK (1) HK1118575A1 (fr)
HU (1) HU229664B1 (fr)
IL (3) IL143905A0 (fr)
MX (1) MXPA01006427A (fr)
NO (1) NO330800B1 (fr)
NZ (1) NZ512574A (fr)
OA (1) OA11736A (fr)
PL (3) PL204073B1 (fr)
PT (3) PT2261358E (fr)
TR (2) TR200200633T2 (fr)
UY (1) UY25877A1 (fr)
WO (1) WO2000039299A2 (fr)
ZA (1) ZA200105114B (fr)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2280072B1 (fr) 1998-02-20 2015-03-25 ID Biomedical Corporation of Quebec Antigènes du streptocoque du groupe B
US20030134407A1 (en) 1998-07-27 2003-07-17 Le Page Richard William Falla Nucleic acids and proteins from Streptococcus pneumoniae
EP1801218A3 (fr) * 1998-07-27 2007-10-10 Sanofi Pasteur Limited Acides nucléiques et protéines de la pneumonie à streptocoques
EP2050464B1 (fr) * 1998-12-21 2019-08-07 Medimmune, Inc. Protéines de streptococcus pneumoniae et fragments immunogènes pour vaccins
EA007409B1 (ru) * 1998-12-23 2006-10-27 Шайе Биокем Инк. Антигенные полипептиды стрептококков, способы их получения и применения
US7128918B1 (en) 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
US6866855B2 (en) 2000-06-12 2005-03-15 University Of Saskatchewan Immunization of dairy cattle with GapC protein against Streptococcus infection
EP1294771B1 (fr) 2000-06-12 2008-10-29 University Of Saskatchewan Protéine chimérique GapC de Streptococcus et son utilisation pour la vaccination et la diagnostique
US6833134B2 (en) 2000-06-12 2004-12-21 University Of Saskacthewan Immunization of dairy cattle with GapC protein against Streptococcus infection
US7074415B2 (en) 2000-06-20 2006-07-11 Id Biomedical Corporation Streptococcus antigens
EP1303612A2 (fr) 2000-06-20 2003-04-23 Shire Biochem Inc. Antigenes de streptocoque
AU2002242549A1 (en) * 2001-03-30 2002-10-15 Shire Biochem Inc. Streptococcus pyogenes antigens and corresponding dna fragments
BR0210875A (pt) 2001-07-06 2004-06-22 Shire Biochem Inc Antìgenos de streptococcus do grupo b e fragmentos de dna correspondentes
GB0130228D0 (en) * 2001-12-18 2002-02-06 Hansa Medica Ab Protein
WO2003054007A2 (fr) * 2001-12-20 2003-07-03 Shire Biochem Inc. Antigenes de streptococcus
SI1601770T1 (sl) * 2003-03-04 2010-01-29 Intercell Ag Streptococcus pyogenes antigeni
CN1774447B (zh) 2003-04-15 2011-04-06 英特塞尔股份公司 肺炎链球菌抗原
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
CA2808919C (fr) 2005-12-22 2016-04-19 Glaxosmithkline Biologicals S.A. Vaccin comportant des conjugues polysaccharides capsulaires streptococcus pneumoniae
DK2167121T3 (en) 2007-06-26 2015-11-23 Glaxosmithkline Biolog Sa A vaccine comprising Streptococcus pneumoniae kapselpolysaccharidkonjugater
KR101595234B1 (ko) * 2007-07-23 2016-02-26 사노피 파스퇴르 리미티드 면역원성 폴리펩타이드 및 단일클론 항체
HUE026586T2 (hu) * 2008-04-16 2016-06-28 Glaxosmithkline Biologicals Sa Vakcina
CA2738245A1 (fr) 2008-09-26 2010-04-01 Nanobio Corporation Compositions therapeutiques de nanoemulsion et procedes d'utilisation de celles-ci
KR101450958B1 (ko) 2009-04-30 2014-10-15 콜레이 파마시티컬 그룹, 인코포레이티드 폐렴구균 백신 및 그의 용도
US8668911B2 (en) 2009-05-14 2014-03-11 The Regents Of The University Of Michigan Streptococcus vaccine compositions and methods of using the same
KR101660578B1 (ko) 2009-09-03 2016-09-27 화이자 백신스 엘엘씨 Ｐｃｓｋ９ 백신
GB201003920D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Method of treatment
US9944680B2 (en) 2010-12-03 2018-04-17 Sandfi Pasteur Limited Composition for immunization against Streptococcus pneumoniae
MX344120B (es) 2011-01-20 2016-12-06 Genocea Biosciences Inc Vacunas y composiciones contra streptococcus pneumoniae.
WO2012131504A1 (fr) 2011-03-02 2012-10-04 Pfizer Inc. Vaccin à base de pcsk9
EA201391456A1 (ru) 2011-05-17 2014-05-30 Глаксосмитклайн Байолоджикалс С.А. ВАКЦИНА ПРОТИВ Streptococcus pneumoniae
WO2013102641A1 (fr) * 2012-01-05 2013-07-11 Deutsches Krebsforschungszentrum Moyens et procédés de diagnostic ou de traitement de cancers positifs au mutant idh1 r132h
CA2894903A1 (fr) * 2012-12-14 2014-06-19 Sanofi Pasteur, Ltd. Methodes pour evaluer l'immunogenicite
MX371453B (es) 2014-01-21 2020-01-29 Pfizer Polisacaridos capsulares de streptococcus pneumoniae y conjugados de los mismos.
AU2015208821B2 (en) 2014-01-21 2017-11-02 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
CN105934251A (zh) 2014-01-21 2016-09-07 辉瑞大药厂 肺炎链球菌荚膜多糖及其缀合物
US11160855B2 (en) 2014-01-21 2021-11-02 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
ES2930318T3 (es) 2014-02-14 2022-12-09 Pfizer Conjugados glucoproteicos inmunogénicos
FI3244917T3 (fi) 2015-01-15 2023-05-25 Pfizer Immunogeenisiä koostumuksia pneumokokkirokotteissa käytettäväksi
TWI756893B (zh) 2015-07-21 2022-03-01 美商輝瑞股份有限公司 包含經共軛之莢膜糖抗原的致免疫性組成物、包含該致免疫性組成物之套組及彼等之用途
GB201518684D0 (en) 2015-10-21 2015-12-02 Glaxosmithkline Biolog Sa Vaccine
CA3005524C (fr) 2015-11-20 2023-10-10 Pfizer Inc. Compositions immunogenes destinees a etre utilisees dans des vaccins pneumococciques
GB201610599D0 (en) 2016-06-17 2016-08-03 Glaxosmithkline Biologicals Sa Immunogenic Composition
DK3570879T3 (da) 2017-01-20 2022-04-11 Pfizer Immunogene sammensætninger til anvendelse i pneumokokvacciner
US11260119B2 (en) 2018-08-24 2022-03-01 Pfizer Inc. Escherichia coli compositions and methods thereof
JP2022512345A (ja) 2018-12-12 2022-02-03 ファイザー・インク 免疫原性多重ヘテロ抗原多糖－タンパク質コンジュゲートおよびその使用
JP7239509B6 (ja) 2019-02-22 2023-03-28 ファイザー・インク 細菌多糖類を精製するための方法
JP2022528158A (ja) 2019-04-10 2022-06-08 ファイザー・インク コンジュゲート化莢膜糖抗原を含む免疫原性組成物、それを含むキットおよびその使用
EP4003410A1 (fr) 2019-07-31 2022-06-01 Sanofi Pasteur, Inc. Compositions de conjugués de polysaccharide-protéine pneumococcique multivalents leurs méthodes d'utilisation
IL292494A (en) 2019-11-01 2022-06-01 Pfizer Preparations of Escherichia coli and their methods
AU2021224078B2 (en) 2020-02-21 2024-01-18 Pfizer Inc. Purification of saccharides
EP4107170A2 (fr) 2020-02-23 2022-12-28 Pfizer Inc. Escherichia coli compositions d'et méthodes associées
EP4232593A1 (fr) 2020-10-22 2023-08-30 Pfizer Inc. Procédés de purification de polysaccharides bactériens
TW202227467A (zh) 2020-10-27 2022-07-16 美商輝瑞大藥廠 大腸桿菌組合物及其方法
KR20230097160A (ko) 2020-11-04 2023-06-30 화이자 인코포레이티드 폐렴구균 백신에 사용하기 위한 면역원성 조성물
US20220202923A1 (en) 2020-12-23 2022-06-30 Pfizer Inc. E. coli fimh mutants and uses thereof
JP2024517780A (ja) 2021-05-03 2024-04-23 ファイザー・インク 細菌およびベータコロナウイルス感染症に対するワクチン接種
WO2022234416A1 (fr) 2021-05-03 2022-11-10 Pfizer Inc. Vaccination contre des infections à pneumocoque et à covid-19
TW202306969A (zh) 2021-05-28 2023-02-16 美商輝瑞大藥廠 包含結合之莢膜醣抗原的免疫原組合物及其用途
PE20240090A1 (es) 2021-05-28 2024-01-16 Pfizer Composiciones inmunogenas que comprenden antigenos de sacarido capsular conjugados y sus usos
WO2023135515A1 (fr) 2022-01-13 2023-07-20 Pfizer Inc. Compositions immunogènes à base d'antigènes saccharidiques capsulaires conjugués et leurs utilisations
WO2023161817A1 (fr) 2022-02-25 2023-08-31 Pfizer Inc. Procédés d'incorporation de groupes azido dans des polysaccharides capsulaires bactériens
WO2023218322A1 (fr) 2022-05-11 2023-11-16 Pfizer Inc. Procédé de production de formulations de vaccin avec des conservateurs
WO2024084397A1 (fr) 2022-10-19 2024-04-25 Pfizer Inc. Vaccination contre infections à pneumocoques et à covid-19

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4425437A (en) 1979-11-05 1984-01-10 Genentech, Inc. Microbial polypeptide expression vehicle
US4431739A (en) 1979-11-05 1984-02-14 Genentech, Inc. Transformant bacterial culture capable of expressing heterologous protein
US4338397A (en) 1980-04-11 1982-07-06 President And Fellows Of Harvard College Mature protein synthesis
KR100331358B1 (ko) * 1993-03-19 2002-08-13 구나르린달 그룹B스트렙토코커스의많은균주들에대한면역성을제공하는세포표면단백질인Rib단백질,그단백질의정제방법,시약키트및제약조성물
PL323781A1 (en) * 1995-06-07 1998-04-27 Biochem Vaccines Inc Streptococco thermal shock proteins belonging to a family hsp70
US5928895A (en) * 1996-09-24 1999-07-27 Smithkline Beecham Corporation IgA Fc binding protein
US5882896A (en) * 1996-09-24 1999-03-16 Smithkline Beecham Corporation M protein
ES2277362T5 (es) * 1996-10-31 2014-12-18 Human Genome Sciences, Inc. Antígenos y vacunas de streptococcus pneumoniae
CA2305016A1 (fr) * 1997-09-24 1999-04-01 Regents Of The University Of Minnesota Proteinase de degradation de la proteine de complement humain c3, tiree du streptococcus pneumoniae
EP1073450A4 (fr) * 1998-04-23 2003-04-23 Uab Research Foundation Proteine de surface pneumococcique c(pspc), regions epitopes et selection de souches d'une telle proteine, et utilisations correspondantes
JP2002521058A (ja) * 1998-07-27 2002-07-16 マイクロビアル テクニクス リミティッド 肺炎連鎖球菌由来の核酸及びタンパク質
ATE361365T1 (de) * 1998-07-27 2007-05-15 Sanofi Pasteur Ltd Streptococcus pneumoniae proteine und nukleinsäuren
IL142017A0 (en) * 1998-09-24 2002-03-10 Univ Minnesota Human complement c3-degrading polypeptide from streptococcus pneumoniae
EP2050464B1 (fr) * 1998-12-21 2019-08-07 Medimmune, Inc. Protéines de streptococcus pneumoniae et fragments immunogènes pour vaccins
EA007409B1 (ru) * 1998-12-23 2006-10-27 Шайе Биокем Инк. Антигенные полипептиды стрептококков, способы их получения и применения

Also Published As

Publication number Publication date
PL206576B1 (pl) 2010-08-31
HK1118575A1 (en) 2009-02-13
AP2001002199A0 (en) 2001-09-30
JP4761623B2 (ja) 2011-08-31
AU1764900A (en) 2000-07-31
DE69938670D1 (de) 2008-06-19
IL194230A0 (en) 2011-08-01
NZ512574A (en) 2004-03-26
NO20013045D0 (no) 2001-06-19
KR101170203B1 (ko) 2012-07-31
OA11736A (en) 2005-06-12
TR200200633T2 (tr) 2002-06-21
EP2261358A2 (fr) 2010-12-15
EP2261358A3 (fr) 2011-02-23
TR200102497T2 (tr) 2002-01-21
HUP0104774A2 (hu) 2002-04-29
CN1191362C (zh) 2005-03-02
EP2261358B1 (fr) 2014-05-14
KR20010104693A (ko) 2001-11-26
CY1115340T1 (el) 2017-01-04
JP2002533123A (ja) 2002-10-08
CN1332803A (zh) 2002-01-23
KR20060134227A (ko) 2006-12-27
CY1108223T1 (el) 2014-02-12
ES2480417T3 (es) 2014-07-28
KR101078919B1 (ko) 2011-11-01
PT1141306E (pt) 2008-07-30
CN101134775A (zh) 2008-03-05
ZA200105114B (en) 2002-11-21
PL205041B1 (pl) 2010-03-31
CA2356836C (fr) 2011-09-13
HU229664B1 (en) 2014-04-28
DK2261358T3 (da) 2014-07-28
AR029322A1 (es) 2003-06-25
EP1141306A2 (fr) 2001-10-10
ES2400280T3 (es) 2013-04-08
IL143905A (en) 2011-05-31
DK1950302T3 (da) 2013-01-14
CZ303675B6 (cs) 2013-02-27
NO330800B1 (no) 2011-07-18
JP5039802B2 (ja) 2012-10-03
WO2000039299A3 (fr) 2000-11-02
CN1654657A (zh) 2005-08-17
BR9916477A (pt) 2004-06-22
KR100891398B1 (ko) 2009-04-02
UY25877A1 (es) 2000-08-21
DK1141306T3 (da) 2008-08-18
CL2009002037A1 (es) 2010-06-25
JP2010142246A (ja) 2010-07-01
PL349777A1 (en) 2002-09-09
CA2356836A1 (fr) 2000-07-06
KR100802198B1 (ko) 2008-02-11
MXPA01006427A (es) 2002-06-04
CY1114722T1 (el) 2016-10-05
CN100398653C (zh) 2008-07-02
CZ302790B6 (cs) 2011-11-09
ES2306528T3 (es) 2008-11-01
PL204073B1 (pl) 2009-12-31
WO2000039299A2 (fr) 2000-07-06
HUP0104774A3 (en) 2007-10-29
EP1141306B1 (fr) 2008-05-07
CZ20012161A3 (cs) 2001-10-17
EA007409B1 (ru) 2006-10-27
KR20100063814A (ko) 2010-06-11
NO20013045L (no) 2001-08-20
IL194230A (en) 2013-12-31
KR20080036666A (ko) 2008-04-28
PT2261358E (pt) 2014-07-30
PT1950302E (pt) 2013-01-16
ATE394489T1 (de) 2008-05-15
EA200100565A1 (ru) 2002-04-25

Similar Documents

Publication Publication Date Title
IL194230A0 (en) Novel streptococcus antigens
IL153558A0 (en) Streptococcus antigens
ZA991325B (en) Novel group B streptococcus antigens.
GB9809839D0 (en) Antibody
PL330111A1 (en) Concentyratyed antibody preparation
AU2002351623A8 (en) Streptococcus antigens
GB9603256D0 (en) Antibodies
PL341642A1 (en) Novel macrolydes
PL346369A1 (en) Streptococcus suis
EP1068213A4 (fr) Nouveaux siloxanes amino-organo-fonctionnels
DE60023158D1 (en) Phagenresistentes streptococcus thermophilus
GB9818915D0 (en) Antibodies
GB9828700D0 (en) Antibody
PL343547A1 (en) Streptococcus preparation
GB9928678D0 (en) Streptococcus pneumoniae antigens
GB9825184D0 (en) Antigen
GB9807062D0 (en) Immune response
GB9819411D0 (en) Antibodies
GB9915419D0 (en) Antigens
IL140295A0 (en) Novel biocontrol agents
GB9800760D0 (en) Antigens
GB9726147D0 (en) Antigens
GB9819015D0 (en) Antigens
GB9822143D0 (en) Antigens
TW407677U (en) Form